Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Silver diamine fluoride + glass ionomer is a combination therapy utilized in restorative dentistry for the management of deep dental caries, particularly for indirect pulp capping in young permanent teeth. Silver diamine fluoride (SDF) is a topical medicament that acts as a potent antimicrobial and caries-arresting agent; its silver ions disrupt bacterial DNA and proteins, while its fluoride ions promote the remineralization of tooth structure to form acid-resistant fluorapatite. Glass ionomer (GI) is a restorative material that chemically bonds to the tooth structure, providing a marginal seal and a sustained release of fluoride to further aid in remineralization. This specific combination is being evaluated by Cairo University in a randomized pilot study to assess its clinical success and impact on postoperative pain in asymptomatic teeth with deep caries and open apices following minimal caries removal.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on silver diamine fluoride + glass ionomer.